© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003

References 4600-4699

4600. M.A. Reidy, S.M. Schwartz, “Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium,” Lab. Invest. 44(April 1981):301-308.

4601. S.M. Schwartz, E.P. Benditt, “Cell replication in the aortic endothelium: A new method for study of the problem,” Lab. Invest. 28(June 1973):699-707; “Aortic endothelial cell replication. I. Effects of age and hypertension in the rat,” Circ. Res. 41(August 1977):248-255.

4602. Ronald L. Heimark, Stephen M. Schwartz, “Endothelial Morphogenesis,” in Nicolae Simionescu, Maya Simionescu, eds., Endothelial Cell Biology in Health and Disease, Plenum Press, New York, 1988, pp. 123-143.

4603. J.M. Wardlaw, P.M. White, “The detection and management of unruptured intracranial aneurysms,” Brain 123(February 2000):205-221.

4604. T. Mizutani, H. Kojima, “Clinicopathological features of non-atherosclerotic cerebral arterial trunk aneurysms,” Neuropathology 20(March 2000):91-97.

4605. S. Inci, R.F. Spetzler, “Intracranial aneurysms and arterial hypertension: a review and hypothesis,” Surg. Neurol. 53(June 2000):530-540, 540-542 (discussion).

4606. A.K. Konstantakos, S.M. Coogan, E.A. Husni, J.H. Raaf, “Aneurysm of the gastroduodenal artery: an unusual cause of obstructive jaundice,” Am. Surg. 66(July 2000):695-698.

4607. L.P. Bignold, S.D. Rogers, T.M. Siaw, J. Bahnisch, “Inhibition of chemotaxis of neutrophil leukocytes to interleukin-8 by endotoxins of various bacteria,” Infect. Immun. 59(November 1991):4255-4258.

4608. A. Shukla, N. Meisler, K.R. Cutroneo, “Perspective article: transforming growth factor-beta: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblasts,” Wound Repair Regen. 7(May-June 1999):133-140.

4609. Robert A. Freitas Jr., Christopher J. Phoenix, “Vasculoid: A personal nanomedical appliance to replace human blood,” Journal of Evolution and Technology, April 2002; http://www.jetpress.org/volume11/vasculoid.html or http://www.jetpress.org/volume11/vasculoid.pdf. See also: Robert A. Freitas Jr., “The vasculoid personal appliance,” Foresight Update No. 48, 31 March 2002, pp. 10-12; http://www.imm.org/Reports/Rep031.html

4610. W. Casscells, “Smooth muscle cell growth factors,” Prog. Growth Factor Res. 3(1991):177-206.

4611. T. Scott-Burden, A.W. Hahn, F.R. Buhler, T.J. Resink, “Vasoactive peptides and growth factors in the pathophysiology of hypertension,” J. Cardiovasc. Pharmacol. 20(1992):S55-S64.

4612. P.E. DiCorleto, “Cellular mechanisms of atherogenesis,” Am. J. Hypertens. 6(November 1993):314S-318S.

4613. P.A. D’Amore, S.R. Smith, “Growth factor effects on cells of the vascular wall: a survey,” Growth Factors 8(1993):61-75.

4614. T. Scott-Burden, P.M. Vanhoutte, “Regulation of smooth muscle cell growth by endothelium-derived factors,” Tex. Heart Inst. J. 21(1994):91-97.

4615. P.E. Chabrier, “Growth factors and vascular wall,” Int. Angiol. 15(June 1996):100-103.

4616. P. Delafontaine, “Growth factors and vascular smooth muscle cell growth responses,” Eur. Heart J. 19(July 1998):G18-G22.

4617. G.A. Stouffer, M.S. Runge, “The role of secondary growth factor production in thrombin-induced proliferation of vascular smooth muscle cells,” Semin. Thromb. Hemost. 24(1998):145-150.

4618. K.E. Bornfeldt, E.W. Raines, L.M. Graves, M.P. Skinner, E.G. Krebs, R. Ross, “Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation,” Ann. N.Y. Acad. Sci. 766(7 September 1995):416-430.

4619. M.K. Patel, J.S. Lymn, G.F. Clunn, A.D. Hughes, “Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells,” Arterioscler. Thromb. Vasc. Biol. 17(October 1997):2107-2114.

4620. B.R. Brehm, C. Bock, S. Wesselborg, S. Pfeiffer, S. Schuler, K. Schulze-Osthoff, “Prevention of human smooth muscle cell proliferation without induction of apoptosis by the topoisomerase I inhibitor topotecan,” Biochem. Pharmacol. 61(1 January 2001):119-127.

4621. A.B. Dodge, X. Lu, P.A. D’Amore, “Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth,” J. Cell Biochem. 53(September 1993):21-31.

4622. D.V. Young, D. Serebryanik, D.R. Janero, S.W. Tam, “Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent,” Mol. Cell Biol. Res. Commun. 4(July 2000):32-36.

4623. M. Raicu, S. Florea, G. Costache, D. Popov, M. Simionescu, “Clotrimazole inhibits smooth muscle cell proliferation and has a vasodilator effect on resistance arteries,” Fundam. Clin. Pharmacol. 14(September-October 2000):477-485.

4624. M. Oberhoff, W. Kunert, C. Herdeg, A. Kuttner, A. Kranzhofer, B. Horch, A. Baumbach, K.R. Karsch, “Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter,” Basic Res. Cardiol. 96(May-June 2001):275-282.

4625. K. Hayashi, H. Takahata, N. Kitagawa, G. Kitange, M. Kaminogo, S. Shibata, “N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury,” Neurol. Res. 23(October 2001):731-738.

4626. N. Ferri, L. Arnaboldi, A. Orlandi, K. Yokoyama, R. Gree, A. Granata, A. Hachem, R. Paoletti, M.H. Gelb, A. Corsini, “Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation,” Biochem. Pharmacol. 62(15 December 2001):1637-1645.

4627. S. Sartore, A. Chiavegato, R. Franch, E. Faggin, P. Pauletto, “Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease,” Arterioscler. Thromb. Vasc. Biol. 17(July 1997):1210-1215.

4628. P. Stralin, S.L. Marklund, “Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression,” Am. J. Physiol. Heart Circ. Physiol. 281(October 2001):H1621-H1629.

4629. Emer P. Reeves, Hui Lu, Hugues Lortat Jacobs, Carlo G.M. Messina, Steve Bolsover, Giorgio Gabella, Eric O. Potma, Alice Warley, Jurgen Roes, Anthony W. Segal, “Killing activity of neutrophils is mediated through activation of proteases by K+ flux,” Nature 416(21 March 2002):291-297.

4630. Stephen R. Wilson, Bernard Erlanger, Bradford Braden, Austin N. Kirschner, “Fullerene Nanotools from Biology,” 9th Foresight Conference on Molecular Nanotechnology, November 2001; http://www.foresight.org/Conferences/MNT9/Abstracts/Wilson/index.html. See also: Bernard F. Erlanger, “Recognition of Single Wall Carbon Nanotubes by an Anti-Fullerene Antibody,” Nanotech and Biotech Convergence-2002, 6-7 May 2000, Stamford, CT, May 7th Session; http://www.bccresearch.com/nanobio2002/.

4631. D.J. Wolff, K. Mialkowski, C.F. Richardson, S.R. Wilson, “C60-fullerene monomalonate adducts selectively inactivate neuronal nitric oxide synthase by uncoupling the formation of reactive oxygen intermediates from nitric oxide production,” Biochemistry 40(9 January 2001):37-45.

4632. D.J. Wolff, C.M. Barbieri, C.F. Richardson, D.I. Schuster, S.R. Wilson, “Trisamine C(60)-fullerene adducts inhibit neuronal nitric oxide synthase by acting as highly potent calmodulin antagonists,” Arch. Biochem. Biophys. 399(15 March 2002):130-141.

4633. S.R. Wilson, M.E. Yurchenko, D.I. Schuster, E.N. Yurchenko, O. Sokolova, S.E. Braslavsky, G. Klihm, “Preparation and photophysical studies of a fluorous phase-soluble fullerene derivative,” J. Am. Chem. Soc. 124(6 March 2002):1977-1981.

4634. S. MacMahon, R. Fong 2nd, P.S. Baran, I. Safonov, S.R. Wilson, D.I. Schuster, “Synthetic approaches to a variety of covalently linked porphyrin-fullerene hybrids,” J. Org. Chem. 66(10 August 2001):5449-5455.

4635. Y. Sun, S.R. Wilson, D.I. Schuster, “High dissolution and strong light emission of carbon nanotubes in aromatic amine solvents,” J. Am. Chem. Soc. 123(6 June 2001):5348-5349.

4636. D.J. Wolff, A.D. Papoiu, K. Mialkowski, C.F. Richardson, D.I. Schuster, S.R. Wilson, “Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts,” Arch. Biochem. Biophys. 378(15 June 2000):216-223.

4637. D. Bassolino-Klimas, H.E. Alper, T.R. Stouch, “Solute diffusion in lipid bilayer membranes: an atomic level study by molecular dynamics simulation,” Biochemistry 32(30 November 1993):12624-12637.

4638. S.W. Chiu, M. Clark, V. Balaji, S. Subramaniam, H.L. Scott, E. Jakobsson, “Incorporation of surface tension into molecular dynamics simulation of an interface: a fluid phase lipid bilayer membrane,” Biophys. J. 69(October 1995):1230-1245.

4639. D. Bassolino, H. Alper, T.R. Stouch, “Drug-membrane interactions studied by molecular dynamics simulation: size dependence of diffusion,” Drug Des. Discov. 13(April 1996):135-141.

4640. S.E. Feller, D. Yin, R.W. Pastor, A.D. MacKerell Jr., “Molecular dynamics simulation of unsaturated lipid bilayers at low hydration: parameterization and comparison with diffraction studies,” Biophys. J. 73(November 1997):2269-2279.

4641. Scott E. Feller, Richard W. Pastor, “Constant surface tension simulations of lipid bilayers: The sensitivity of surface areas and compressibilities,” J. Chem. Phys. 111(15 July 1999):1281-1287; http://persweb.wabash.edu/facstaff/fellers/publications/jcp7_15.pdf

4642. S.E. Feller, “Molecular dynamics simulation of phospholipid bilayers,” in John Katsaras, Thomas Gutberlet, eds., Lipid Bilayers, Springer, New York, 2000, pp. 89-107; S.E. Feller, “Molecular dynamics simulations of lipid bilayers,” J. Curr. Opin. Coll. Int. Sci. 5(2000):217-223.

4643. P. Lague, M.J. Zuckermann, B. Roux, “Lipid-mediated interactions between intrinsic membrane proteins: dependence on protein size and lipid composition,” Biophys. J. 81(July 2001):276-284.

4644. T.X. Xiang, B.D. Anderson, “A computer simulation of functional group contributions to free energy in water and a DPPC lipid bilayer,” Biophys. J. 82(April 2002):2052-2066.

4645. Li-Tsun Chen, Leon Weiss, “The role of the sinus wall in the passage of erythrocytes through the spleen,” Blood 41(April 1973):529-537.

4646. J.M. Norton, “The effect of macrocytosis on rat erythrocyte deformability during recovery from phenylhydrazine-induced anemia,” Biorheology 27(1990):21-37.

4647. A. Tozeren, K.L. Sung, L.A. Sung, M.L. Dustin, P.Y. Chan, T.A. Springer, S. Chien, “Micromanipulation of adhesion of a Jurkat cell to a planar bilayer membrane containing lymphocyte function-associated antigen 3 molecules,” J. Cell Biol. 116(February 1992):997-1006.

4648. K.L. Sung, P. Kuhlman, F. Maldonado, B.A. Lollo, S. Chien, A.A. Brian, “Force contribution of the LFA-1/ICAM-1 complex to T cell adhesion,” J. Cell Sci. 103(September 1992):259-266.

4649. Ben Fabry, Geoffrey N. Maksym, James P. Butler, Michael Glogauer, Daniel Navajas, Jeffrey J. Fredberg, “Scaling the microrheology of living cells,” Phys. Rev. Lett. 87(1 October 2001):148102; http://link.aps.org/abstract/PRL/v87/e148102, http://focus.aps.org/v8/st16.html

4650. B. Yaszay, M.C. Trindade, M. Lind, S.B. Goodman, R.L. Smith, “Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro,” J. Orthop. Res. 19(September 2001):970-976.

4651. M. Yoshida, K. Masuyama, N. Ogata, Y. Samejima, M. Eura, T. Ishikawa, “Local production of interleukin-5 by T lymphocytes is associated with recruitment of eosinophils in patients with eosinophilic granuloma of the soft tissue,” Int. Arch. Allergy Immunol. 111(October 1996):133-141.

4652. V.M. Lima, V.L. Bonato, K.M. Lima, S.A. Dos Santos, R.R. Dos Santos, E.D. Goncalves, L.H. Faccioli, I.T. Brandao, J.M. Rodrigues-Junior, C.L. Silva, “Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis,” Infect. Immun. 69(September 2001):5305-5312.

4653. I. Matsunaga, S. Oka, N. Fujiwara, I. Yano, “Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycoloyl glycolipids from Rhodococcus ruber (Nocardia rubra),” J. Biochem. (Tokyo) 120(September 1996):663-670.

4654. N. Ishiguro, T. Kojima, T. Ito, S. Saga, H. Anma, K. Kurokouchi, Y. Iwahori, T. Iwase, H. Iwata, “Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components,” J. Biomed. Mater. Res. 35(5 June 1997):399-406.

4655. D. Smith, H. Hansch, G. Bancroft, S. Ehlers, “T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma,” Immunology 92(December 1997):413-421.

4656. B. Qiu, K.A. Frait, F. Reich, E. Komuniecki, S.W. Chensue, “Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation,” Am. J. Pathol. 158(April 2001):1503-1515.

4657. C.M. Hogaboam, S.W. Chensue, M.L. Steinhauser, G.B. Huffnagle, N.W. Lukacs, R.M. Strieter, S.L. Kunkel, “Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide,” J. Immunol. 159(1 December 1997):5585-5593.

4658. G. Senaldi, S. Yin, C.L. Shaklee, P.F. Piguet, T.W. Mak, T.R. Ulich, “Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI,” J. Immunol. 157(1 December 1996):5022-5026.

4659. K.S. Warmington, L. Boring, J.H. Ruth, J. Sonstein, C.M. Hogaboam, J.L. Curtis, S.L. Kunkel, I.R. Charo, S.W. Chensue, “Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses,” Am. J. Pathol. 154(May 1999):1407-1416; http://ajp.amjpathol.org/cgi/content/full/154/5/1407

4660. X. Shang, B. Qiu, K.A. Frait, J.S. Hu, J. Sonstein, J.L. Curtis, B. Lu, C. Gerard, S.W. Chensue, “Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation,” Am. J. Pathol. 157(December 2000):2055-2063.

4661. J.H. Ruth, K.S. Warmington, X. Shang, P. Lincoln, H. Evanoff, S.L. Kunkel, S.W. Chensue, “Interleukin 4 and 13 participation in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation: multiparameter analysis of cellular recruitment, chemokine expression and cytokine networks,” Cytokine 12(May 2000):432-444.

4662. M. Hirata, M. Kage, T. Hara, M. Nakao, T. Fukuma, “Inhibitory effect of circulating egg antigens on Schistosoma japonicum egg-induced granuloma formation,” J. Parasitol. 83(October 1997):842-847.

4663. D.L. Boros, J.R. Whitfield, “Enhanced Th1 and dampened Th2 responses synergize to inhibit acute granulomatous and fibrotic responses in murine schistosomiasis mansoni,” Infect. Immun. 67(March 1999):1187-1193; http://iai.asm.org/cgi/content/full/67/3/1187

4664. X. Song, L. Zeng, C.M. Pilo, J. Zagorski, S.M. Wahl, “Inhibition of bacterial cell wall-induced leukocyte recruitment and hepatic granuloma formation by TGF-beta gene transfer,” J. Immunol. 163(1 October 1999):4020-4026; http://www.jimmunol.org/cgi/content/full/163/7/4020

4665. W.W. Wilson, M.M. Wade, S.C. Holman, F.R. Champlin, “Status of methods for assessing bacterial cell surface charge properties based on zeta potential measurements,” J. Microbiol. Methods 43(January 2001):153-164.

4666. A.A. Peterson, R.E.W. Hancock, E.J. McGroarty, “Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa,” J. Bacteriology 164(December 1985):1256-1261.

4667. M. Rivera, E.J. McGroarty, “Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa,” J. Bacteriology 171(April 1989):2244-2248.

4668. J.S. Lam, L.L. Graham, J. Lightfoot, T. Dasgupta, T.J. Beveridge, “Ultrastructural examination of the lipopolysaccharides of Pseudomonas aeruginosa strains and their isogenic rough mutants by freeze-substitution,” J. Bacteriology 174(November 1992):7159-7167.

4669. S.A. Makin, T.J. Beveridge, “The influence of A-band and B-band lipopolysaccharide on the surface characteristics and adhesion of Pseudomonas aeruginosa to surfaces,” Microbiology 142(February 1996):299-307.

4670. M. Espinosa-Cantellano, A. Gonzales-Robles, B. Chavez, G. Castanon, C. Arguello, A. Lazaro-Haller, A. Martinez-Palomo, “Entamoeba dispar: ultrastructure, surface properties and cytopathic effect,” J. Eukaryot. Microbiol. 45(May-June 1998):265-272.

4671. M.E. Bayer, J.L. Sloyer Jr., “The electrophoretic mobility of gram-negative and gram-positive bacteria: an electrokinetic analysis,” J. Gen. Microbiol. 136(May 1990):867-874.

4672. B.A. Jucker, H. Harms, A.J. Zehnder, “Adhesion of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon,” J. Bacteriol. 178(September 1996):5472-5479; http://jb.asm.org/cgi/reprint/178/18/5472

4673. K.L. Anderson, “Cationized ferritin as a stain for electron microscopic observation of bacterial ultrastructure,” Biotech. Histochem. 73(September 1998):278-288.

4674. K. Ahmed, T. Nakagawa, Y. Nakano, G. Martinez, A. Ichinose, C.H. Zheng, M. Akaki, M. Aikawa, T. Nagatake, “Attachment of Moraxella catarrhalis occurs to the positively charged domains of pharyngeal epithelial cells,” Microb. Pathog. 28(April 2000):203-209.

4675. S. Nomura, A. Kuroiwa, A. Nagayama, “Changes of surface hydrophobicity and charge of Staphylococcus aureus treated with sub-MIC of antibiotics and their effects on the chemiluminescence response of phagocytic cells,” Chemotherapy 41(March-April 1995):77-81.

4676. M. Muratsugu, Y. Miyake, N. Ishida, A. Hyodo, K. Terayama, “Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria,” Biol. Pharm. Bull. 18(September 1995):1259-1263.

4677. Y.E. Collins, G. Stotzky, “Heavy metals alter the electrokinetic properties of bacteria, yeasts, and clay minerals,” Appl. Environ. Microbiol. 58(May 1992):1592-1600.

4678. Y.E. Collins, G. Stotzky, “Changes in the surface charge of bacteria caused by heavy metals do not affect survival,” Can. J. Microbiol. 42(July 1996):621-627.

4679. G. Harkes, J. Feijen, J. Dankert, “Adhesion of Escherichia coli on to a series of poly(methacrylates) differing in charge and hydrophobicity,” Biomaterials 12(November 1991):853-860.

4680. S.A. Beers, A.G. Buckland, R.S. Koduri, W. Cho, M.H. Gelb, D.C. Wilton, “The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall,” J. Biol. Chem. 277(18 January 2002):1788-1793.

4681. H. Nagura, J. Asai, Y. Katsumata, K. Kojima, “Role of electric surface charge of cell membrane in phagocytosis,” Acta Pathol. Jpn. 23(May 1973):279-290.

4682. F. Ahsan, I.P. Rivas, M.A. Khan, A.I. Torres Suarez, “Targeting to macrophages: role of physicochemical properties of particulate carriers – liposomes and microspheres – on the phagocytosis by macrophages,” J. Control Release 79(19 February 2002):29-40.

4683. K.E. Magnusson, O. Stendahl, I. Stjernstrom, L. Edebo, “The effect of colostrum and colostral antibody SIgA on the physico-chemical properties and phagocytosis of Escherichia coli o86,” Acta Pathol. Microbiol. Scand. B 86(April 1978):113-120.

4684. R.L. Hoover, R. Folger, W.A. Haering, B.R. Ware, M.J. Karnovsky, “Adhesion of leukocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate,” J. Cell Sci. 45(October 1980):73-86.

4685. A. Cockayne, C.W. Penn, M.J. Bailey, “Surface properties of Treponema pallidum in relation to phagocytosis by human polymorphonuclear leucocytes in vitro,” J. Gen. Microbiol. 132(January 1986):133-141.

4686. H. Saito, H. Tomioka, T. Watanabe, K. Sato, “Mechanisms of phagocytosis of Mycobacterium leprae and other mycobacteria by human oligodendroglial cells,” Infect. Immun. 51(January 1986):163-167.

4687. E. Kilhstrom, “Interaction between Salmonella bacteria and mammalian nonprofessional phagocytes,” Am. J. Clin. Nutr. 33(November 1980):2491-2501.

4688. K.E. Magnusson, J. Davies, T. Grundstrom, E. Kihlstrom, S. Normark, “Surface charge and hydrophobicity of Salmonella, E. coli, Gonococci in relation to their tendency to associate with animal cells,” Scand. J. Infect. Dis. Suppl. 24(1980):135-140.

4689. K.E. Magnusson, O. Stendahl, I. Stjernstrom, L. Edebo, “Reduction of phagocytosis, surface hydrophobicity and charge of Salmonella typhimurium 395 MR10 by reaction with secretory IgA (SIgA),” Immunology 36(March 1979):439-447.

4690. T. Sano, N. Muramatsu, T. Kondo, “Phagocytosis of microcapsules by guinea-pig polymorphonuclear leucocytes,” J. Microencapsul. 3(October-December 1986):265-273.

4691. L. Thiele, B. Rothen-Rutishauser, S. Jilek, H. Wunderli-Allenspach, H.P. Merkle, E. Walter, “Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?” J. Control Release 76(11 September 2001):59-71.

4692. R.A. Schwendener, P.A. Lagocki, Y.E. Rahman, “The effects of charge and size on the interaction of unilamellar liposomes with macrophages,” Biochim. Biophys. Acta 772(25 April 1984):93-101.

4693. J.V. Johnson, I.A. Montoya, D.L. Olive, “Ethiodol oil contrast medium inhibits macrophage phagocytosis and adherence by altering membrane electronegativity and microviscosity,” Fertil. Steril. 58(September 1992):511-517.

4694. G. Guidotti, “Membrane proteins,” Annu. Rev. Biochem. 41(1972):731-752.

4695. C. Tanford, The Hydrophobic Effect, John Wiley and Sons, New York, 1980, p. 109.

4696. D. Voet, J. G. Voet, “Chapter 11. Lipids and Membranes,” Biochemistry, John Wiley and Sons, New York, 1990, pp. 284-285.

4697. P.M. Ajayan, M. Terrones, A. de la Guardia, V. Huc, N. Grobert, B.Q. Wei, H. Lezec, G. Ramanath, T.W. Ebbesen, “Nanotubes in a flash – ignition and reconstruction,” Science 296(26 April 2002):705.

4698. G.D. Hoke, K. Draper, S.M. Freier, C. Gonzalez, V.B. Driver, M.C. Zounes, D.J. Ecker, “Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection,” Nucleic Acids Res. 19(25 October 1991):5743-5748.

4699. L.L. Cummins, S.R. Owens, L.M. Risen, E.A. Lesnik, S.M. Freier, D. McGee, C.J. Guinosso, P.D. Cook, “Characterization of fully 2’-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity,” Nucleic Acids Res. 23(11 June 1995):2019-2024.

Last updated on 16 April 2004